Audio Recording

Merck & Addex BioBusiness presentation on 02/27/2008.

Vincent Mutel, CEO of Addex, and Jane Devereux, senior director, corporate licensing at Merck & Co., Inc., gave a joint presentation at the BioBusiness 2008 conference in Geneva to talk about how the mGluR4 PAM and ADX63365 deals were established. Jane was very complimentary with regard to the quality of Addex science and business acumen. The presentation was very well received by a prestigious group including key players in the pharmaceutical and biotech industries. Here is a copy of the slide presentation.

Please find below the conference on streaming media. Click the green arrow on left or the button just to the right of it to play or pause, respectively; click the green arrows on the right to skip forward or backward. There are a few seconds of silence at the beginning of the recording. Please be patient or skip forward!

[duration: 00:39:14 - quality rate: 64kb/s]